Loading bill…
Loading bill…
H.R. 2592 · House bill · 119th Congress
This bill directs the Federal Aviation Administration (FAA) to compile, publish, and annually update a list of medications that may be safely prescribed to pilots and air traffic controllers for the purposes of issuing a medical certification. The list must be publicly available on the FAA website and distributed to those seeking a license and medical certification.
Currently, the FAA does not have a list of approved medications. However, the FAA does have lists for Aviation Medical Examiners of Do Not Issue medications and Do Not Fly medications.
This Act may be cited as the “Aviation Medication Transparency Act of 2025”.
(a) In general.— Not later than 1 year after the date of enactment of this Act, the Administrator of the Federal Aviation Administration shall publish and maintain on a publicly available website of the Administration the list of medications and treatments that may be safely prescribed to an airman to treat certain medical conditions that the Administrator has compiled for purposes of the issuance of a medical certification to an airman.
(b) Requirements.— The list required under subsection (a) shall—
(1) be drafted in consultation with—
(A) the Aeromedical Innovation and Modernization Working Group;
(B) the certified exclusive bargaining representatives of air traffic controllers of the Administration certified under section 7111 of title 5, United States Code;
(C) the principal organization representing the largest certified collective bargaining representative of airline pilots; and
(D) any other stakeholder determined relevant by the task group, including any stakeholders described in section 411(d)(3)(B) of the FAA Reauthorization Act of 2024;
(2) be comprehensive;
(3) be drafted in a user-friendly and accessible manner and provided to airmen at the time when such airmen first seek a license and medical certification;
(4) indicate what, if any, period of time, on average, an airman must have limited or no duties to stabilize on an approved medication;
(5) include the list of medications that the Administrator has designated as “Do Not Issue”;
(6) include a mechanism for doctors or medical providers to contact the Federal Aviation Administration regarding questions related to such list;
(7) include any additional information that the Administrator determines is appropriate to provide with respect to what conditions a certain medication may or may not be used to treat and any information to explain why a medication is allowed or prohibited by the Federal Aviation Administration; and
(8) include any other information or clarification that the Administrator determines appropriate.
(c) Annual update.— Not later than 1 year after the date of publication of the list required under subsection (a), and annually thereafter, the Administrator shall update such list, as appropriate.